Amgen
AstraZeneca
Bristol Myers Squibb
F-Star Therapeutics
GlaxoSmithKline
Immutep
Innovent
Macrogenics
Merck
Nanobiotix
Novartis
Ono Pharmaceutical
Pfizer
Roche
Shanghai Junshi Biosciences
Published | Pages | Publisher | Report code |
---|---|---|---|
Jan 2022 | 900 | Kuick Research | ASDR-597952 |
Amgen
AstraZeneca
Bristol Myers Squibb
F-Star Therapeutics
GlaxoSmithKline
Immutep
Innovent
Macrogenics
Merck
Nanobiotix
Novartis
Ono Pharmaceutical
Pfizer
Roche
Shanghai Junshi Biosciences